Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease

9 Feb 2023

Abstract excerpt

BACKGROUND AND AIMS: NAFLD is one of the fast-growing health problems that affects up to 25% of people worldwide. Numerous miRNAs have been clarified as important regulators of liver pathophysiology, including NAFLD. Thus, we investigated the expression of the MiRNA-34a and MiRNA-192 as diagnostic markers for NAFLD. PATIENTS AND METHODS: Blood samples were collected from NAFLD cases and healthy controls. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to Liver Disease Diagnosis and Treatment
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36757530
DOI: 10.1186/s43141-023-00467-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver diseasePMID 36757530Read ↗

Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive reviewSemantic proximity Read ↗

miRNA Signature in NAFLD: A Turning Point for a Non-Invasive DiagnosisSemantic proximity Read ↗

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectivesSemantic proximity Read ↗

miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular DiseaseSemantic proximity Read ↗

miRNAs and NAFLD: from pathophysiology to therapySemantic proximity Read ↗

Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLDSemantic proximity Read ↗

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCCSemantic proximity Read ↗

MicroRNAs in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Dual Role of MicroRNAs in NAFLDSemantic proximity Read ↗

Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis BiomarkersSemantic proximity Read ↗

Elucidation of novel miRNA candidates and their role in unraveling the pathology of Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.